BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12125944)

  • 21. [Topical treatment of alopecia areata with dinitrochlorobenzol (DNCB)].
    Kratka J; Goerz G
    Z Hautkr; 1979 Sep; 54(18):813-6. PubMed ID: 539028
    [No Abstract]   [Full Text] [Related]  

  • 22. Contact urticaria during topical immunotherapy.
    Tosti A; Guerra L; Bardazzi F
    Contact Dermatitis; 1989 Sep; 21(3):196-7. PubMed ID: 2791547
    [No Abstract]   [Full Text] [Related]  

  • 23. Induction of hair growth in alopecia areata with D.N.C.B.
    Happle R; Echternacht K
    Lancet; 1977 Nov; 2(8046):1002-3. PubMed ID: 72899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical immunotherapy of alopecia areata. A follow-up study.
    Valsecchi R; Cainelli T; Foiadelli L; Rossi A
    Acta Derm Venereol; 1986; 66(3):269-72. PubMed ID: 2426909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical immunotherapy in dermatology.
    Buckley DA; du Vivier AW
    Int J Clin Pract; 1999 Mar; 53(2):130-7. PubMed ID: 10344049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical inquiries: childhood alopecia areata: what treatment works best?
    Haynes JW; Persons R; Jamieson B
    J Fam Pract; 2011 Jan; 60(1):45-52. PubMed ID: 21209981
    [No Abstract]   [Full Text] [Related]  

  • 27. Alopecia areata.
    Weitzner JM
    Am Fam Physician; 1990 Apr; 41(4):1197-201. PubMed ID: 2181836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of alopecia areata with D.N.C.B. (author's transl)].
    De Prost Y; Paquez FR; Touraine R
    Ann Dermatol Venereol; 1979 May; 106(5):437-40. PubMed ID: 496207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy for resistant and/or severe alopecia areata in a university hospital setting in Northern Mexico.
    Herz-Ruelas ME; Lozano-Peña AK; Ocampo-Candiani J; Gómez-Flores M; Welsh-Lozano O; Vázquez-Martínez O
    Australas J Dermatol; 2020 Feb; 61(1):e137-e139. PubMed ID: 31385296
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the therapeutic effect of DNBC-induced contact dermatitis in alopecia areata].
    Broniarczyk-Dyła G; Omulecki A
    Przegl Dermatol; 1983; 70(5-6):557-61. PubMed ID: 6366925
    [No Abstract]   [Full Text] [Related]  

  • 31. Topical immunotherapy in children with alopecia areata.
    Orecchia G; Malagoli P
    J Invest Dermatol; 1995 May; 104(5 Suppl):35S-36S. PubMed ID: 7738389
    [No Abstract]   [Full Text] [Related]  

  • 32. Topical sensitizers in alopecia areata.
    McMichael AJ; Henderson RL
    Dermatol Nurs; 2004 Aug; 16(4):333-6. PubMed ID: 15471045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of efficacy of topical imiquimod in the treatment of patchy alopecia areata.
    Koc E; Tunca M; Akar A; Kurumlu Z
    Int J Dermatol; 2008 Oct; 47(10):1088-9. PubMed ID: 18986369
    [No Abstract]   [Full Text] [Related]  

  • 34. [Alopecia areata: successful half-side treatment with DNCB].
    Happle R; Echternacht K
    Z Hautkr; 1977 Nov; 52(22):1129-34. PubMed ID: 595747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Disappointing results with dinitrochlorobenzene in alopecia areata (author's transl)].
    Lindemayr H
    Wien Klin Wochenschr; 1981 Feb; 93(4):131-4. PubMed ID: 7281686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical immune modulation (TIM): a novel approach to the immunotherapy of systemic disease.
    Stricker RB; Goldberg B; Epstein WL
    Immunol Lett; 1997 Dec; 59(3):145-50. PubMed ID: 9419021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.
    Ajith C; Gupta S; Kanwar AJ
    J Drugs Dermatol; 2006 Mar; 5(3):262-6. PubMed ID: 16573260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The therapeutic use of topical contact sensitizers in benign dermatoses.
    Buckley DA; Du Vivier AW
    Br J Dermatol; 2001 Sep; 145(3):385-405. PubMed ID: 11531828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified immunotherapy for alopecia areata.
    Yoshimasu T; Furukawa F
    Autoimmun Rev; 2016 Jul; 15(7):664-7. PubMed ID: 26932732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contact immunotherapy-induced Renbök phenomenon in a patient with alopecia areata and psoriasis vulgaris.
    Ito T; Hashizume H; Takigawa M
    Eur J Dermatol; 2010; 20(1):126-7. PubMed ID: 19822483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.